1. Home
  2. Investor Relations
  3. Announcements and Circulars
Announcements and Circulars Financial Reports Prospectus Corporate Governance Contact IR
PROXY FORM FOR THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
2026-07-15
Download
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
2026-07-15
Download
(1) PROPOSED CHANGE OF EXTERNAL AUDITOR FOR THE YEAR 2026 (2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR AND (3) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
2026-07-15
Download
PREPARATION OF FINANCIAL REPORTS IN ACCORDANCE WITH CASBE AND PROPOSED CHANGE OF AUDITOR
2026-07-15
Download
PREPARATION OF FINANCIAL REPORTS IN ACCORDANCE WITH CASBE AND PROPOSED CHANGE OF AUDITOR
2026-07-15
Download
VOLUNTARY ANNOUNCEMENT - HXP089 INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR THE TREATMENT OF GLIOBLASTOMA APPROVED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA)
2026-07-14
Download
About Us
Technology
Products
News
Investor Relations
Careers
Contact Us

Fujian Haixi Pharmaceutical Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min)-Non-operating-2023-0063

Some texts and images on this website are sourced from the Internet for sharing and learning purposes only. If any content infringes your rights and interests, please notify us promptly, and we will handle or remove the relevant materials without delay.